Effectiveness of Factor XIII Infusion in Treatment of Refractory Ureteral Leakage after Kidney Transplantation.


Journal

Case reports in transplantation
ISSN: 2090-6943
Titre abrégé: Case Rep Transplant
Pays: United States
ID NLM: 101591863

Informations de publication

Date de publication:
2020
Historique:
received: 20 03 2020
revised: 19 06 2020
accepted: 03 07 2020
entrez: 30 7 2020
pubmed: 30 7 2020
medline: 30 7 2020
Statut: epublish

Résumé

Despite the evolution of transplantation techniques, urological complications are common and result in loss of graft. We report the case of a 57-year-old man who developed continuous urine leakage despite pyeloureteral neoanastomosis and stenting after kidney transplantation from his dizygotic twin. Suspecting ureteral leakage, we performed pyeloureteral neoanastomosis using his native right ureter and a ureteral stent 5 days after the kidney transplant. However, urine leakage continued for several days. Because the plasma factor XIII level decreased to 48%, we administered factor XIII products (Fibrogammin P; CSL Behring, King of Prussia, PA) after the surgery. Although its utility and safety in patients with renal failure and/or transplantation are unclear, urine leakage stopped after the infusion of fibrogammin without any side effects. This is the first case report of the use of factor XIII for refractory urine leakage after kidney transplantation. Although further studies are needed, administration of factor XIII products could be one option for refractory urine leakage after transplantation.

Identifiants

pubmed: 32724697
doi: 10.1155/2020/1780760
pmc: PMC7381963
doi:

Types de publication

Case Reports

Langues

eng

Pagination

1780760

Informations de copyright

Copyright © 2020 Ryoichi Maenosono et al.

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

BJU Int. 2002 Nov;90(7):627-34
pubmed: 12410737
Transfus Apher Sci. 2013 Oct;49(2):254-8
pubmed: 23827327
Blood. 2002 Aug 1;100(3):743-54
pubmed: 12130481
Transplant Proc. 2014 Dec;46(10):3455-8
pubmed: 25498071
Arch Pathol Lab Med. 2014 Feb;138(2):278-81
pubmed: 24476525
Transplantation. 2002 Oct 27;74(8):1190-2
pubmed: 12438970
Transplantation. 2001 Oct 27;72(8):1456-8
pubmed: 11685121
World J Transplant. 2018 Sep 10;8(5):142-149
pubmed: 30211022
Transfus Med Hemother. 2016 Sep;43(5):365-373
pubmed: 27781024
Transpl Int. 2007 Aug;20(8):702-7
pubmed: 17511829
Surg Today. 2010 Jul;40(7):626-31
pubmed: 20582513

Auteurs

Ryoichi Maenosono (R)

Department of Urology, Osaka Medical College, Osaka, Japan.

Tomohisa Matsunaga (T)

Department of Urology, Osaka Medical College, Osaka, Japan.

Hajime Hirano (H)

Department of Urology, Osaka Medical College, Osaka, Japan.

Hayahito Nomi (H)

Department of Urology, Osaka Medical College, Osaka, Japan.

Shunri Taniguchi (S)

Department of Urology, Osaka Medical College, Osaka, Japan.

Yuya Fujiwara (Y)

Department of Urology, Osaka Saiseikai Nakatsu Hospital, Osaka, Japan.

Koichiro Minami (K)

Department of Urology, Nozaki Tokushukai Hospital, Osaka, Japan.

Hirofumi Uehara (H)

Department of Urology, Osaka Medical College, Osaka, Japan.

Teruo Inamoto (T)

Department of Urology, Osaka Medical College, Osaka, Japan.

Haruhito Azuma (H)

Department of Urology, Osaka Medical College, Osaka, Japan.

Classifications MeSH